Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-enabled Emergency Clinical Research for Emerging and Re-emerging Infectious Diseases: Protocol for an International Consensus

NCT07678619 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT07678619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07678619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-enabled Emergency Clinical Research for Emerging and Re-emerging Infectious Diseases: Protocol for an International Consensus
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 10, 2026
Completion date
July 31, 2027
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avian influenza, chikungunya fever, covid-19, dengue fever, emerging infectious diseases, influenza, mpox (monkeypox)